0001564590-21-040270.txt : 20210803 0001564590-21-040270.hdr.sgml : 20210803 20210803162436 ACCESSION NUMBER: 0001564590-21-040270 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210803 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210803 DATE AS OF CHANGE: 20210803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Benefitfocus, Inc. CENTRAL INDEX KEY: 0001576169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 462346314 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36061 FILM NUMBER: 211140183 BUSINESS ADDRESS: STREET 1: 100 BENEFITFOCUS WAY CITY: CHARLESTON STATE: SC ZIP: 29492 BUSINESS PHONE: 843-849-7476 MAIL ADDRESS: STREET 1: 100 BENEFITFOCUS WAY CITY: CHARLESTON STATE: SC ZIP: 29492 FORMER COMPANY: FORMER CONFORMED NAME: Benefitfocus,Inc. DATE OF NAME CHANGE: 20130507 8-K 1 bnft-8k_20210803.htm 8-K bnft-8k_20210803.htm
false 0001576169 0001576169 2021-08-03 2021-08-03

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 3, 2021

 

BENEFITFOCUS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

(State or other jurisdiction of incorporation)

 

 

 

 

001-36061

 

46-2346314

(Commission File Number)

 

(IRS Employer Identification No.)

100 Benefitfocus Way, Charleston, South Carolina 29492

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (843) 849-7476

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.001 Par Value

 

BNFT

 

Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this Chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this Chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


 

Item 2.02   Results of Operations and Financial Condition.

On August 3, 2021, Benefitfocus, Inc. issued a press release announcing its operating results for the quarter ended June 30, 2021.  A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01   Financial Statements and Exhibits.

(d)   Exhibits

         Exhibit No.     Description                                  

          99.1                Press release dated August 3, 2021.

          104                 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BENEFITFOCUS, INC.

 

 

 

Date: August 3, 2021

 

/s/ Alpana Wegner

 

 

Alpana Wegner

 

 

Chief Financial Officer

(Principal financial and accounting officer)

 

 EX-99.1 2 bnft-ex991_6.htm EX-99.1 bnft-ex991_6.htm

 

Exhibit 99.1

 

Benefitfocus, Inc.

843-981-8898

pr@benefitfocus.com

 

Investor Relations:

Patti Leahy

843-981-8899

ir@benefitfocus.com   

 

 

 

 

Benefitfocus Announces Second Quarter 2021 Financial Results 

Delivers on second quarter financial commitments

Raising bar towards industry leadership in service excellence

 

Charleston, S.C. – August 3, 2021 –  Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, today announces its second quarter 2021 financial results.  

 

Second quarter financial highlights:  

 

•

Revenue of $60.9 million exceeds high end of guidance

 

•

GAAP EPS of ($0.50) vs. ($0.38) in second quarter 2020

 

•

Non-GAAP EPS of ($0.18) vs. ($0.26) in second quarter 2020

 

•

Adjusted EBITDA of $9.6 million, up 4% year over year

 

•

Operating cash flow of $9.2 million and free cash flow of $6.6 million

 

•

Cash and marketable securities of $193 million, up $4 million from prior quarter

 

Other recent highlights:

 

•

Announced addition of four accomplished and experienced industry leaders to Benefitfocus management team

 

•

Strengthened board experience, independence and diversity with addition of John Park

 

•

Added full suite of voluntary benefits offerings from Standard Insurance Company to Benefit Catalog

 

•

Delivered product enhancements for shopping and quoting functions for Health Plans to further simplify selling and distribution through an automated, insight-driven experience for brokers and groups

 

 

“Building a great business starts with building a great team,” said Matt Levin, president and chief executive officer. “I’m excited about the management announcements we made earlier today and believe we have attracted some of the best talent in the industry. My expectation is for these key additions, together with the dedicated team we have in place today, to raise the bar on service excellence in our industry. I believe delivering an exceptional customer experience is our most important priority and our biggest lever to drive higher levels of sustainable organic growth.”

 

“Benefitfocus again delivered on our financial commitments,” said Alpana Wegner, chief financial officer. “We are regaining momentum and seeing particularly strong traction in the public sector as we look to return to pre-pandemic levels. We continued to generate free cash flow and have a solid cash position which gives us the flexibility to invest strategically in order to advance our growth strategy.”

 

Second Quarter 2021 Financial Highlights

 

Revenue

 

•

Total revenue was $60.9 million, down 2% compared to the second quarter of 2020.

 

•

Software services was $50.2 million, up 1% compared to the second quarter of 2020. Software services is comprised of subscription and platform revenue.

 

o

Subscription revenue was $44.3 million, up 1% compared to the second quarter of 2020.

 

o

Platform revenue was $5.9 million, down 4% compared to the second quarter of 2020.

 

•

Professional services revenue was $10.7 million, down 13% compared to the second quarter of 2020.

Net Loss

 

•

GAAP net loss available to common stockholders was ($16.6) million, compared to ($12.3) million in the second quarter of 2020. GAAP net loss per share was ($0.50), based on 33.1 million basic and diluted weighted average common shares outstanding, compared to ($0.38) for the second quarter of 2020, based on 32.1 million basic and diluted weighted average common shares outstanding.

Non-GAAP Net Loss, Adjusted EBITDA and Free Cash Flow

 

•

Non-GAAP net loss available to common stockholders was ($5.9) million compared to ($8.2) million in the second quarter of 2020. Non-GAAP net loss per share was ($0.18) based on 33.1 million basic and diluted weighted average common shares outstanding, compared to ($0.26) in the second quarter of 2020, based on 32.1 million basic and diluted weighted average common shares outstanding.

 

•

Adjusted EBITDA was $9.6 million, compared to $9.3 million in the second quarter of 2020.

 

•

Free cash flow was $6.6 million, compared to $6.2 million in the second quarter of 2020.

See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below.

Balance Sheet

 

•

Cash and cash equivalents and marketable securities at June 30, 2021 totaled $193.2 million, compared to $188.9 million at the end of the first quarter of 2021.

 

•

The full $50.0 million line of credit remains available to the company.

Business Outlook

Based on information available as of August 3, 2021, Benefitfocus is providing guidance for the third quarter as indicated below.

Third Quarter 2021

 

•

Total revenue is expected to be in the range of $58 million to $60 million.

 

•

Adjusted EBITDA is expected to be in the range of $5 million to $7 million.

 

•

Non-GAAP net loss available to common stockholders is expected to be between ($10.5) and ($8.0) million, or between ($0.31) and ($0.24) per share based on 33.1 million basic and diluted shares outstanding.

Full Year 2021

The company is reiterating guidance previously provided for Full Year 2021 as follows:

 

•

Total revenue is expected to be in the range of $254 million to $260 million.

 

•

Adjusted EBITDA is expected to be in the range of $44 million to $50 million.

 

 

 

•

Free cash flow is expected to be in the range of $20 million to $26 million.

Adjusted EBITDA and free cash flow guidance excludes the impact of restructuring and impairment charges.

Management has not reconciled forward-looking non-GAAP net loss, adjusted EBITDA or free cash flow to their most directly comparable GAAP measure of GAAP net loss or GAAP operating cash flows. This is because we cannot predict with reasonable certainty the ultimate outcome of the various necessary GAAP components of such reconciliations, including, for example, those related to compensation, acquisition transactions and integration, or others that may arise during the year, without unreasonable effort. These components and other factors could materially impact the amount of future directly comparable GAAP measures, which may differ significantly from their non-GAAP counterparts. See below for additional important disclosures regarding our non-GAAP financial measures.

Conference Call Details:

In conjunction with this announcement, Benefitfocus will host a conference call to discuss the company’s financial results and business outlook on Tuesday, August 3, 2021, at 5:00 p.m. ET. To access this call, dial (855) 327-6837 (domestic) or +1 (631) 891-4304 (international). A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/. After the conference call, a replay will be available until August 10, 2021, and can be accessed by dialing (844) 512-2921 (domestic) or +1 (412) 317-6671 (international) with passcode 10015779.

About Benefitfocus

Benefitfocus (NASDAQ: BNFT) unifies the entire benefits industry through innovative technology solutions that bring efficiency, cost savings and simplicity to employee benefits administration. Our powerful cloud-based software, data-driven insights and thoughtfully designed services help employers, insurance brokers, health plans and suppliers address the complexity of benefits enrollment and engagement, while bringing easier access to health, wealth and lifestyle products through a world-class benefits experience. Our mission is simple: to improve lives with benefits. 

 

Non-GAAP Financial Measures

The company uses certain non-GAAP financial measures in this release, including non-GAAP gross profit, operating income/loss, net loss/income, net loss/income per common share, adjusted EBITDA and free cash flow. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. 

Non-GAAP gross profit, operating income/loss, net loss/income and net loss/income per common share exclude stock-based compensation expenses, amortization of acquisition-related intangible assets, transaction and acquisition-related costs expensed, expense related to the impairment of goodwill, intangible assets and long-lived assets, gain or loss on extinguishment of debt, and costs not core to our business. We define adjusted EBITDA as net loss before net interest, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense, expense related to the impairment of goodwill, intangible assets and long-lived assets, transaction and acquisition-related costs expensed, restructuring costs, gain or loss on extinguishment of debt, and costs not core to our business. We define free cash flow as cash provided by or used in operating activities less capital expenditures, adjusted to eliminate restructuring costs. Please note that other companies might define their non-GAAP financial measures differently than we do.

Management presents these non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, their inclusion should provide consistency in the company’s financial reporting.

 

Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release, including in the accompanying tables.

Safe Harbor Statement

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our continuing losses and need to achieve GAAP profitability; fluctuations in our financial results; our ability to maintain our culture and recruit, integrate and retain qualified personnel, including our board; our ability to compete effectively and implement our growth strategy; the need to innovate and provide useful products and services; the immature and volatile nature of the market for our products and services; risks related to changing healthcare and other applicable regulations; privacy; security and other risks associated with our business; management of growth; volatility and uncertainty in the global economy and financial markets in light of the evolving COVID-19 pandemic; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our Investor Relations Department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

 

Source: Benefitfocus, Inc.

 


 

 

 

Benefitfocus, Inc.

Unaudited Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data)

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenue

 

$

60,904

 

 

$

62,174

 

 

$

125,967

 

 

$

128,328

 

Cost of revenue(1)(2)(3)

 

 

28,030

 

 

 

30,397

 

 

 

56,623

 

 

 

64,309

 

Gross profit

 

 

32,874

 

 

 

31,777

 

 

 

69,344

 

 

 

64,019

 

Operating expenses:(1)(2)(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

10,921

 

 

 

11,828

 

 

 

21,812

 

 

 

27,458

 

Research and development

 

 

11,103

 

 

 

11,045

 

 

 

21,935

 

 

 

22,813

 

General and administrative

 

 

17,574

 

 

 

9,381

 

 

 

27,436

 

 

 

19,896

 

Restructuring costs

 

 

2,727

 

 

 

5,616

 

 

 

4,127

 

 

 

5,616

 

Total operating expenses

 

 

42,325

 

 

 

37,870

 

 

 

75,310

 

 

 

75,783

 

Loss from operations

 

 

(9,451

)

 

 

(6,093

)

 

 

(5,966

)

 

 

(11,764

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

54

 

 

 

97

 

 

 

111

 

 

 

523

 

Interest expense

 

 

(5,646

)

 

 

(5,862

)

 

 

(11,201

)

 

 

(11,753

)

Other income

 

 

64

 

 

 

2

 

 

 

22

 

 

 

7

 

Total other expense, net

 

 

(5,528

)

 

 

(5,763

)

 

 

(11,068

)

 

 

(11,223

)

Loss before income taxes

 

 

(14,979

)

 

 

(11,856

)

 

 

(17,034

)

 

 

(22,987

)

Income tax expense

 

 

41

 

 

 

6

 

 

 

83

 

 

 

11

 

Net loss

 

 

(15,020

)

 

 

(11,862

)

 

 

(17,117

)

 

 

(22,998

)

Preferred dividends

 

 

(1,600

)

 

 

(462

)

 

 

(3,200

)

 

 

(462

)

Net loss available to common stockholders

 

$

(16,620

)

 

$

(12,324

)

 

$

(20,317

)

 

$

(23,460

)

Comprehensive loss

 

$

(15,020

)

 

$

(11,862

)

 

$

(17,117

)

 

$

(22,998

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.50

)

 

$

(0.38

)

 

$

(0.62

)

 

$

(0.73

)

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

33,080,257

 

 

 

32,058,387

 

 

 

32,787,162

 

 

 

32,348,673

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Stock-based compensation included in above line items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

638

 

 

$

633

 

 

$

964

 

 

$

1,300

 

Sales and marketing

 

 

927

 

 

 

594

 

 

 

1,507

 

 

 

1,474

 

Research and development

 

 

503

 

 

 

590

 

 

 

621

 

 

 

932

 

General and administrative

 

 

2,308

 

 

 

1,506

 

 

 

2,807

 

 

 

3,294

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Amortization of acquired intangible assets included in above line items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

336

 

 

$

323

 

 

$

673

 

 

$

640

 

Sales and marketing

 

 

77

 

 

 

83

 

 

 

153

 

 

 

174

 

Research and development

 

 

113

 

 

 

114

 

 

 

226

 

 

 

223

 

General and administrative

 

 

43

 

 

 

48

 

 

 

85

 

 

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3) Transaction and acquisition-related costs expensed included in above line items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

$

6

 

 

$

215

 

 

$

160

 

 

$

407

 

 


 

 

Benefitfocus, Inc.

Unaudited Consolidated Balance Sheets

(in thousands, except share and per share data)

 

 

As of

June 30,

2021

 

 

As of

December 31,

2020

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

98,062

 

 

$

90,706

 

Marketable securities

 

 

95,107

 

 

 

95,085

 

Accounts receivable, net

 

 

20,886

 

 

 

22,240

 

Contract, prepaid and other current assets

 

 

18,838

 

 

 

21,354

 

Total current assets

 

 

232,893

 

 

 

229,385

 

Property and equipment, net

 

 

27,001

 

 

 

29,701

 

Financing lease right-of-use assets

 

 

60,291

 

 

 

68,670

 

Operating lease right-of-use assets

 

 

986

 

 

 

1,107

 

Intangible assets, net

 

 

9,257

 

 

 

10,393

 

Goodwill

 

 

12,857

 

 

 

12,857

 

Deferred contract costs and other non-current assets

 

 

9,011

 

 

 

10,259

 

Total assets

 

$

352,296

 

 

$

362,372

 

Liabilities, redeemable preferred stock and stockholders' deficit

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

3,639

 

 

$

2,160

 

Accrued expenses

 

 

8,177

 

 

 

6,262

 

Accrued compensation and benefits

 

 

14,223

 

 

 

19,129

 

Deferred revenue, current portion

 

 

28,202

 

 

 

27,782

 

Lease liabilities and financing obligations, current portion

 

 

7,104

 

 

 

5,959

 

Total current liabilities

 

 

61,345

 

 

 

61,292

 

Deferred revenue, net of current portion

 

 

3,387

 

 

 

4,422

 

Convertible senior notes

 

 

190,089

 

 

 

184,308

 

Lease liabilities and financing obligations, net current portion

 

 

78,344

 

 

 

79,282

 

Other non-current liabilities

 

 

2,629

 

 

 

2,470

 

Total liabilities

 

 

335,794

 

 

 

331,774

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Redeemable preferred stock:

 

 

 

 

 

 

 

 

Series A preferred stock, par value $0.001, 5,000,000 shares

  authorized, 1,777,778 and 1,777,778 shares issued and outstanding

  at June 30, 2021 and December 31, 2020, respectively,

  liquidation preference $45 per share as of June 30, 2021 and December 31, 2020,   respectively

 

 

79,193

 

 

 

79,193

 

Stockholders' deficit:

 

 

 

 

 

 

 

 

Common stock, par value $0.001, 95,000,000 and 50,000,000 shares authorized,

   33,234,786 and 32,327,439 issued and outstanding at June 30, 2021 and December 31, 2020, respectively

 

 

33

 

 

 

32

 

Additional paid-in capital

 

 

430,451

 

 

 

427,431

 

Accumulated deficit

 

 

(493,175

)

 

 

(476,058

)

Total stockholders' deficit

 

 

(62,691

)

 

 

(48,595

)

Total liabilities, redeemable preferred stock and stockholders' deficit

 

$

352,296

 

 

$

362,372

 

 


 

 

Benefitfocus, Inc.

Unaudited Consolidated Statements of Cash Flows

(in thousands)

 

 

Six Months Ended

June 30,

 

 

 

2021

 

 

2020

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net loss

 

$

(17,117

)

 

$

(22,998

)

Adjustments to reconcile net loss to net cash and cash

   equivalents provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

12,525

 

 

 

12,105

 

Stock-based compensation expense

 

 

5,899

 

 

 

7,000

 

Accretion of interest on convertible senior notes

 

 

5,780

 

 

 

5,894

 

Interest accrual on finance lease liabilities

 

 

3,244

 

 

 

44

 

Rent expense less than payments

 

 

(27

)

 

 

(16

)

Non-cash interest income on short-term investments

 

 

506

 

 

 

–

 

Impairment or loss on disposal of right-of-use assets and property and equipment

 

 

4,048

 

 

 

–

 

Provision for doubtful accounts

 

 

–

 

 

 

111

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

1,354

 

 

 

3,711

 

Accrued interest on short-term investments

 

 

(101

)

 

 

–

 

Contract, prepaid and other current assets

 

 

2,410

 

 

 

3,672

 

Deferred costs and other non-current assets

 

 

1,249

 

 

 

740

 

Accounts payable and accrued expenses

 

 

3,520

 

 

 

(7,318

)

Accrued compensation and benefits

 

 

(4,907

)

 

 

(4,139

)

Deferred revenue

 

 

(615

)

 

 

(2,850

)

Other non-current liabilities

 

 

159

 

 

 

1,910

 

Net cash and cash equivalents provided by (used in) operating activities

 

 

17,927

 

 

 

(2,134

)

Cash flows from investing activities

 

 

 

 

 

 

 

 

Purchases of short-term investments held to maturity

 

 

(48,427

)

 

 

–

 

Proceeds from short-term investments held to maturity

 

 

48,000

 

 

 

–

 

Purchases of property and equipment

 

 

(4,483

)

 

 

(7,075

)

Net cash and cash equivalents used in investing activities

 

 

(4,910

)

 

 

(7,075

)

Cash flows from financing activities

 

 

 

 

 

 

 

 

Draws on revolving line of credit

 

 

–

 

 

 

10,000

 

Payments on revolving line of credit

 

 

–

 

 

 

(10,000

)

Payments of debt issuance costs

 

 

–

 

 

 

(154

)

Proceeds from issuance of preferred stock, net of issuance costs

 

 

–

 

 

 

79,840

 

Payments of preferred dividends

 

 

(3,200

)

 

 

(462

)

Repurchase of common stock

 

 

–

 

 

 

(9,667

)

Proceeds from exercises of stock options and ESPP

 

 

322

 

 

 

225

 

Payments on financing obligations

 

 

(224

)

 

 

(416

)

Payments of principal on finance lease liabilities

 

 

(2,559

)

 

 

(7,637

)

Net cash and cash equivalents (used in) provided by financing activities

 

 

(5,661

)

 

 

61,729

 

Net increase in cash and cash equivalents

 

 

7,356

 

 

 

52,520

 

Cash and cash equivalents, beginning of period

 

 

90,706

 

 

 

130,976

 

Cash and cash equivalents, end of period

 

$

98,062

 

 

$

183,496

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing activities

 

 

 

 

 

 

 

 

Property and equipment purchases in accounts payable and accrued expenses

 

$

–

 

 

$

37

 

 


 

 

Benefitfocus, Inc.

Unaudited Reconciliation of GAAP to Non-GAAP Measures

(in thousands, except share and per share data)

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Reconciliation from Gross Profit to Non-GAAP Gross Profit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

$

32,874

 

 

$

31,777

 

 

$

69,344

 

 

$

64,019

 

Amortization of acquired intangible assets

 

 

336

 

 

 

323

 

 

 

673

 

 

 

640

 

Stock-based compensation expense

 

 

638

 

 

 

633

 

 

 

964

 

 

 

1,300

 

Total net adjustments

 

 

974

 

 

 

956

 

 

 

1,637

 

 

 

1,940

 

Non-GAAP gross profit

 

$

33,848

 

 

$

32,733

 

 

$

70,981

 

 

$

65,959

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation from Operating Loss to Non-GAAP Operating Income (Loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating loss

 

$

(9,451

)

 

$

(6,093

)

 

$

(5,966

)

 

$

(11,764

)

Amortization of acquired intangible assets

 

 

569

 

 

 

568

 

 

 

1,137

 

 

 

1,137

 

Stock-based compensation expense

 

 

4,376

 

 

 

3,323

 

 

 

5,899

 

 

 

7,000

 

Transaction and acquisition-related costs expensed

 

 

6

 

 

 

215

 

 

 

160

 

 

 

407

 

Impairment of long-lived assets

 

 

4,003

 

 

 

—

 

 

 

4,003

 

 

 

—

 

Costs not core to our business

 

 

1,717

 

 

 

—

 

 

 

3,598

 

 

 

—

 

Total net adjustments

 

 

10,671

 

 

 

4,106

 

 

 

14,797

 

 

 

8,544

 

Non-GAAP operating income (loss)

 

$

1,220

 

 

$

(1,987

)

 

$

8,831

 

 

$

(3,220

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation from Net Loss to Adjusted EBITDA:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(15,020

)

 

$

(11,862

)

 

$

(17,117

)

 

$

(22,998

)

Depreciation

 

 

3,444

 

 

 

3,926

 

 

 

7,067

 

 

 

7,722

 

Amortization of software development costs

 

 

2,159

 

 

 

1,727

 

 

 

4,321

 

 

 

3,246

 

Amortization of acquired intangible assets

 

 

569

 

 

 

568

 

 

 

1,137

 

 

 

1,137

 

Interest income

 

 

(54

)

 

 

(97

)

 

 

(111

)

 

 

(523

)

Interest expense

 

 

5,646

 

 

 

5,862

 

 

 

11,201

 

 

 

11,753

 

Income tax expense

 

 

41

 

 

 

6

 

 

 

83

 

 

 

11

 

Stock-based compensation expense

 

 

4,376

 

 

 

3,323

 

 

 

5,899

 

 

 

7,000

 

Transaction and acquisition-related costs expensed

 

 

6

 

 

 

215

 

 

 

160

 

 

 

407

 

Restructuring costs

 

 

2,727

 

 

 

5,616

 

 

 

4,127

 

 

 

5,616

 

Impairment of long-lived assets

 

 

4,003

 

 

 

—

 

 

 

4,003

 

 

 

—

 

Costs not core to our business

 

 

1,717

 

 

 

—

 

 

 

3,598

 

 

 

—

 

Total net adjustments

 

 

24,634

 

 

 

21,146

 

 

 

41,485

 

 

 

36,369

 

Adjusted EBITDA

 

$

9,614

 

 

$

9,284

 

 

$

24,368

 

 

$

13,371

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation from Net Loss to Non-GAAP Net Loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(15,020

)

 

$

(11,862

)

 

$

(17,117

)

 

$

(22,998

)

Amortization of acquired intangible assets

 

 

569

 

 

 

568

 

 

 

1,137

 

 

 

1,137

 

Stock-based compensation expense

 

 

4,376

 

 

 

3,323

 

 

 

5,899

 

 

 

7,000

 

Transaction and acquisition-related costs expensed

 

 

6

 

 

 

215

 

 

 

160

 

 

 

407

 

Impairment of long-lived assets

 

 

4,003

 

 

 

—

 

 

 

4,003

 

 

 

—

 

Costs not core to our business

 

 

1,717

 

 

 

—

 

 

 

3,598

 

 

 

—

 

Total net adjustments

 

 

10,671

 

 

 

4,106

 

 

 

14,797

 

 

 

8,544

 

Non-GAAP net loss

 

$

(4,349

)

 

$

(7,756

)

 

$

(2,320

)

 

$

(14,454

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Non-GAAP Earnings Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net loss

 

$

(4,349

)

 

$

(7,756

)

 

$

(2,320

)

 

$

(14,454

)

Preferred dividends

 

 

(1,600

)

 

 

(462

)

 

 

(3,200

)

 

 

(462

)

Non-GAAP net loss available to common stockholders

 

$

(5,949

)

 

$

(8,218

)

 

$

(5,520

)

 

$

(14,916

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic and diluted

 

 

33,080,257

 

 

 

32,058,387

 

 

 

32,787,162

 

 

 

32,348,673

 

Shares used in computing non-GAAP net loss per share - basic and diluted

 

 

33,080,257

 

 

 

32,058,387

 

 

 

32,787,162

 

 

 

32,348,673

 

Non-GAAP net loss per common share - basic and diluted

 

$

(0.18

)

 

$

(0.26

)

 

$

(0.17

)

 

$

(0.46

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Cash Flows from Operations to Free Cash Flow:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash and cash equivalents provided by (used in) operating activities

 

$

9,163

 

 

$

5,036

 

 

$

17,927

 

 

$

(2,134

)

Purchases of property and equipment

 

 

(2,590

)

 

 

(3,254

)

 

 

(4,483

)

 

 

(7,075

)

Cash paid for restructuring costs

 

 

5

 

 

 

4,456

 

 

 

1,384

 

 

 

4,456

 

Total net adjustments

 

 

(2,585

)

 

 

1,202

 

 

 

(3,099

)

 

 

(2,619

)

Free Cash Flow

 

$

6,578

 

 

$

6,238

 

 

$

14,828

 

 

$

(4,753

)

 

 GRAPHIC 3 gvvhen1plcoe000001.jpg GRAPHIC begin 644 gvvhen1plcoe000001.jpg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end EX-101.SCH 4 bnft-20210803.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 bnft-20210803_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 6 bnft-20210803_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 bnft-8k_20210803_htm.xml IDEA: XBRL DOCUMENT 0001576169 2021-08-03 2021-08-03 false 0001576169 8-K 2021-08-03 BENEFITFOCUS, INC. DE 001-36061 46-2346314 100 Benefitfocus Way Charleston SC 29492 (843) 849-7476 false false false false Common Stock, $0.001 Par Value BNFT NASDAQ false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Aug. 03, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 03, 2021
Entity Registrant Name BENEFITFOCUS, INC.
Entity Central Index Key 0001576169
Entity Emerging Growth Company false
Entity File Number 001-36061
Entity Incorporation State Country Code DE
Entity Tax Identification Number 46-2346314
Entity Address, Address Line One 100 Benefitfocus Way
Entity Address, City or Town Charleston
Entity Address, State or Province SC
Entity Address, Postal Zip Code 29492
City Area Code (843)
Local Phone Number 849-7476
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 Par Value
Trading Symbol BNFT
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bnft-8k_20210803.htm bnft-20210803.xsd bnft-20210803_lab.xml bnft-20210803_pre.xml bnft-ex991_6.htm http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bnft-8k_20210803.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "bnft-8k_20210803.htm" ] }, "labelLink": { "local": [ "bnft-20210803_lab.xml" ] }, "presentationLink": { "local": [ "bnft-20210803_pre.xml" ] }, "schema": { "local": [ "bnft-20210803.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "bnft", "nsuri": "http://www.benefitfocus.com/20210803", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "bnft-8k_20210803.htm", "contextRef": "C_0001576169_20210803_20210803", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "bnft-8k_20210803.htm", "contextRef": "C_0001576169_20210803_20210803", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.benefitfocus.com/20210803/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001564590-21-040270-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-040270-xbrl.zip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end